Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-12

Clinical Trial Update: Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on allogeneic bone marrow transplant for inherited metabolic disorders; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Mucopolysaccharidosis, Hurler Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12